ModeratePlant alkaloid (isoquinoline), food supplement×Selective serotonin reuptake inhibitors (SSRIs)
Updated · Methodology
Mechanism
Sertraline is metabolised in the liver by several pathways, including CYP3A4, CYP2C19 and CYP2B6, and has an elimination half-life of about 26 hours (Besitran SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 5.2). According to its SmPC, CYP3A4 inhibition raises sertraline levels: three glasses of grapefruit juice a day roughly doubled them, and strong and moderate CYP3A4 inhibitors may raise them even more (Besitran SmPC, AEMPS, section 4.5). Berberine is a plant alkaloid. It is not authorised as a medicine in Spain and is sold as a food supplement, usually at 250–500 mg two or three times a day (LiverTox, NIH). In healthy men, berberine 300 mg three times a day for two weeks inhibited CYP2D6, CYP2C9 and CYP3A4: exposure to midazolam, a CYP3A4 substrate, rose by 40% (Guo et al., 2012). Berberine has not been studied together with sertraline, so how much sertraline levels would rise is unknown.
Symptoms
If sertraline levels rise, its serotonin-related effects become stronger: drowsiness, nausea and vomiting, tachycardia, tremor, agitation and dizziness. According to its SmPC, this is how sertraline overdose presents (Besitran SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.9). In people with diabetes, SSRIs such as sertraline can alter glycaemic control (Besitran SmPC, AEMPS, section 4.4). Berberine is taken, among other reasons, to lower blood glucose (LiverTox, NIH). Berberine's adverse effects are usually mild and transient: nausea, bloating, diarrhoea or constipation. In controlled trials they were no more frequent than with placebo, and no liver injury from berberine has been described (LiverTox, NIH).
Management
The combination can be used with monitoring. According to the sertraline SmPC, CYP3A4 inhibition raises sertraline levels (Besitran SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.5), and berberine inhibits CYP3A4 in humans (Guo et al., 2012). In the first weeks after berberine is started or its dose is increased, nausea, tremor, agitation, drowsiness and palpitations are watched for. If they appear or get worse, berberine is stopped. People with diabetes check their blood glucose more often during this time because, according to the sertraline SmPC, the doses of insulin or oral antidiabetic drugs may need adjusting (Besitran SmPC, AEMPS, section 4.4).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- AEMPS: Ficha técnica: Sertralina (Besitran 50 mg) (nº registro 59717), secciones 4.4 y 4.5 (2025)– AEMPS, CIMA, nº registro 59717, revisión 08/2025, secciones 4.4 y 4.5
- European journal of clinical pharmacology: Repeated administration of berberine inhibits cytochromes P450 in humans. (2012)– Repeated administration of berberine inhibits cytochromes P450 in humans.. European journal of clinical pharmacology 2012. PMID 21870106.
- LiverTox NIDDK: Berberine – LiverTox (2020)– LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, NIDDK, Berberine, last update 06.10.2020